9 November 2015. The FDA warning dated Thursday followed a quarter in which Dr Reddy’s posted a record profit of Rs.722 crore on the back of strong demand in North America, which contributes about 60% of total generic drug sales for the company.



At industryabout.com:

India - Pharmaceutical Industry Checklist (206 Facilities)

India - Chemical Industry Map

You can post comments after registration

This site uses only session 3rd party cookies.

If you dont change browser settings you agree with it.

I understand